Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 126; no. 3; pp. e22 - e24
Main Authors Lightman, Sue, Niederer, Rachael, Sharma, Srilakshmi, Hooper, Claire, Tomkins-Netzer, Oren, Kramer, Michal, Damato, Erika Marie, Peebo, Beatrice, McCluskey, Peter
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2019
Subjects
Adalimumab
Antirheumatic Agents
Arthritis, Juvenile
Cost-Benefit Analysis
Humans
Uveitis
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0161-6420
1549-4713
DOI:10.1016/j.ophtha.2018.12.004